Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease (ASSERT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01058018
Recruitment Status : Completed
First Posted : January 28, 2010
Last Update Posted : July 22, 2016
Information provided by (Responsible Party):
Resverlogix Corp

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2010
  Study Completion Date : No date given
  Certification/Extension First Submitted : October 23, 2013